Veach J

References (6)

Title : Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial - Farlow_2003_Arch.Neurol_60_843
Author(s) : Farlow M , Potkin S , Koumaras B , Veach J , Mirski D
Ref : Archives of Neurology , 60 :843 , 2003
Abstract : Farlow_2003_Arch.Neurol_60_843
ESTHER : Farlow_2003_Arch.Neurol_60_843
PubMedSearch : Farlow_2003_Arch.Neurol_60_843
PubMedID: 12810489

Title : Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease - Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713
Author(s) : Potki SG , Anand R , Hartman R , Veach J , Grossberg G
Ref : Prog Neuropsychopharmacol Biological Psychiatry , 26 :713 , 2002
Abstract : Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713
ESTHER : Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713
PubMedSearch : Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713
PubMedID: 12188104

Title : Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression - Farlow_2001_Arch.Neurol_58_417
Author(s) : Farlow MR , Hake A , Messina J , Hartman R , Veach J , Anand R
Ref : Archives of Neurology , 58 :417 , 2001
Abstract : Farlow_2001_Arch.Neurol_58_417
ESTHER : Farlow_2001_Arch.Neurol_58_417
PubMedSearch : Farlow_2001_Arch.Neurol_58_417
PubMedID: 11255445

Title : An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors - Kumar_2000_Eur.J.Neurol_7_159
Author(s) : Kumar V , Anand R , Messina J , Hartman R , Veach J
Ref : Eur Journal of Neurology , 7 :159 , 2000
Abstract : Kumar_2000_Eur.J.Neurol_7_159
ESTHER : Kumar_2000_Eur.J.Neurol_7_159
PubMedSearch : Kumar_2000_Eur.J.Neurol_7_159
PubMedID: 10809936

Title : A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease - Farlow_2000_Eur.Neurol_44_236
Author(s) : Farlow M , Anand R , Messina J, Jr. , Hartman R , Veach J
Ref : Eur Neurol , 44 :236 , 2000
Abstract : Farlow_2000_Eur.Neurol_44_236
ESTHER : Farlow_2000_Eur.Neurol_44_236
PubMedSearch : Farlow_2000_Eur.Neurol_44_236
PubMedID: 11096224

Title : Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications - Grossberg_2000_Int.J.Geriatr.Psychiatry_15_242
Author(s) : Grossberg GT , Stahelin HB , Messina JC , Anand R , Veach J
Ref : Int J Geriatr Psychiatry , 15 :242 , 2000
Abstract : Grossberg_2000_Int.J.Geriatr.Psychiatry_15_242
ESTHER : Grossberg_2000_Int.J.Geriatr.Psychiatry_15_242
PubMedSearch : Grossberg_2000_Int.J.Geriatr.Psychiatry_15_242
PubMedID: 10713582